German real-world data from over 10 years in the TYSABRI (R) Observational Program: long-term effectiveness of natalizumab treatment in German patients with relapsing-remitting MS
- Resource Type
- Journal
- Source
MULTIPLE SCLEROSIS JOURNAL ; OCT 2018, 24 p290-p290, 1p. Supplement: 2- Subject
- Language
- English
- ISSN
- 14770970